Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature

Journal of Inherited Metabolic Disease

Volumn 40, Issue 2, 2017, Pages 195-207

  Marques da Silva, D ^a,b,c   dos Reis Ferreira, V ^b,c   Monticelli, M ^a,d   Janeiro, P ^e   Videira, P A ^a,b,c   Witters, P ^c,f   Jaeken, J ^c,f   Cassiman, D ^c,f  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b Portuguese Association for Congenital Disorders of Glycosylation (CDG)   (Portugal)

^c Professional and Patient Association International Network (PPAIN)   (Portugal)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e Endocrinology Department   (Portugal)

^f UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CONGENITAL DISORDER OF GLYCOSYLATION; ENDOPLASMIC RETICULUM; EXERCISE TOLERANCE; FIBROADENOMA; GLYCOSYLATION; HUMAN; IMMUNE DEFICIENCY; ISOELECTRIC FOCUSING; ISOLATED LIVER; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER FIBROSIS; LIVER TRANSPLANTATION; LUNG FUNCTION; METABOLIC PARAMETERS; PARTIAL THROMBOPLASTIN TIME; PATIENT IDENTIFICATION; PROTHROMBIN TIME; REVIEW; LIVER; PATHOLOGY;

CONGENITAL DISORDERS OF GLYCOSYLATION; GLYCOSYLATION; HUMANS; LIVER;

EID: 85009921397     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-016-0012-4     Document Type: Review

References (73)

1. AlSubhi S, AlHashem A, AlAzami A et al (2015) Further delineation of the ALG9-CDG phenotype. JIMD Rep 27:107–112
2. Arnoux JB, Boddaert N, Valayannopoulos V et al (2008) Risk assessment of acute vascular events in congenital disorder of glycosylation type Ia. Mol Genet Metab 93:444–449
3. Aronica E, van Kempen AAMW, van der Heide M et al (2005) Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology. Acta Neuropathol 109:433–442
4. Babovic-Vuksanovic D, Patterson MC, Schwenk WF et al (1999) Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome. J Pediatr 135:775–781
5. Barone R, Sturiale L, Fiumara A, Uziel G, Garozzo D, Jaeken J (2007) Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype). J Inherit Metab Dis 30:107
6. Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H (2009) Alteration of protein glycosylation in liver diseases. J Hepatol 50:592–603
7. Chantret I, Dancourt J, Dupre T et al (2003) A deficiency in dolichyl-P-glucose: Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation. J Biol Chem 298:9962–9971
8. Choi R, Woo HI, Choe B-H (2015) Application of whole exome sequencing to a rare inherited metabolic disease with neurological and gastrointestinal manifestations: a congenital disorder of glycosylation mimicking glycogen storage disease. Clin Chim Acta 444:50–53
9. Damen G, de Klerk H, Huijmans J, den Hollander J, Sinaasappel M (2004) Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type Ia, Ib, and Ic. J Pediatr Gastroenterol Nutr 38:282–287
10. de Koning TJ, Dorland L, van Diggelen OP et al (1998) A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. Biochem Biophys Res Commun 245:38–42
11. de Lonlay P, Seta N (2009) The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. Biochim Biophys Acta 1792:841–843
12. de Lonlay P, Seta N, Barrot S et al (2001) A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet 38:14–19
13. Eklund EA, Sun L, Westphal V, Northrop JL, Freeze HH, Scaglia F (2005) Congenital disorder of glycosylation (CDG)-Ih patient with a severe hepato-intestinal phenotype and evolving central nervous system pathology. J Pediatr 147:847–850
14. Eklund EA, Sun L, Yang SP, Pasion RM, Thorland EC, Freeze HH (2006) Congenital disorder of glycosylation Ic due to a de novo deletion and an hALG-6 mutation. Biochem Biophys Res Commun 339:755–760
15. Ferro JM, Viana P, Santos P (2016) Management of neurologic manifestations in patients with liver disease. Curr Treat Options Neurol 18:37
16. Foulquier F, Vasile E, Schollen E et al (2006) Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. PNAS 103:3764–3769
17. Frank CG, Grubenmann CE, Eyaid W, Berger EG, Aebi M, Hennet T (2004) Identification and functional analysis of a defect in the human ALG9 Gene: definition of congenital disorder of glycosylation type IL. Am J Hum Genet 75:146–150
18. Freeze HH, Chong JX, Bamshad MJ, Ng BG (2014) Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am J Hum Genet 94:161–175
19. Fung CW, Matthijs G, Sturiale L et al (2012) COG5-CDG with a mild neurohepatic presentation. JIMD Rep 3:67–70
20. Grubenmann CE, Frank CG, Hülsmeier AJ et al (2004) Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik. Hum Mol Genet 13:535–542
21. Grünewald S (2009) The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). Biochim Biophys Acta 1792:827–834
22. Grünewald S, De Vos R, Jaeken J (2003) Abnormal lysosomal inclusions in liver hepatocytes but not in fibroblasts in congenital disorders of glycosylation (CDG). J Inherit Metab Dis 26:49–54
23. Hendriksz CJ, McClean P, Henderson MJ et al (2001) Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose. Arch Dis Child 85:339–340
24. Hernández EM, Vega Pajares AIV, González BP et al (2008) Defecto congénito de glucosilación tipo Ib. experiencia en el tratamiento con manosa. An Pediatr (Barc) 69:358–365
25. Höck M, Wegleiter K, Ralser E et al (2015) ALG8-CDG: novel patients and review of the literature. Orphanet J Rare Dis 10:73–80
26. Jaeken J, Morava E (2016) Congenital disorders of glycosylation and dolichol and glycosylphosphatidylinositol metabolism. In: Saudubray, Baumgartner, Walter (ed) Inborn metabolic diseases. diagnosis and treatment, 6th edn. Springer, Berlin, pp 607–622
27. Jaeken J, Stibler H, Hagberg B (1991) The carbohydrate-deficient glycoprotein syndrome. a new inherited multisystemic disease with severe nervous system involvement. Acta Paediatr Scand Suppl 375:1–71
28. Jaeken J, Matthijs G, Saudubray J-M et al (1998) Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet 62:1535–1539
29. Jaeken J, Lefeber D, Matthijs G (2014) Clinical utility gene card for: phosphomannose isomerase deficiency. Eur J Hum Genet. doi:10.1038/ejhg.2014.29
30. Jaeken J, Lefeber D, Matthijs G (2015a) Clinical utility gene card for: ALG1 defective congenital disorder of glycosylation. Eur J Hum Genet. doi:10.1038/ejhg.2015.9
31. Jaeken J, Lefeber D, Matthijs G (2015b) Clinical utility gene card for: ALG6 defective congenital disorder of glycosylation. Eur J Hum Genet. doi:10.1038/ejhg.2014.146
32. Jansen JC, Timal S, van Scherpenzeel M et al (2016a) TMEM199 deficiency is a disorder of Golgi homeostasis characterized by elevated aminotransferases, alkaline phosphatase, and cholesterol and abnormal glycosylation. Am J Hum Genet 98:322–330
33. Jansen JC, Cirak S, van Scherpenzeel M et al (2016b) CCDC115 deficiency causes a disorder of golgi homeostasis with abnormal protein glycosylation. Am J Hum Genet 98:310–321
34. Jansen EJR, Timal S, Ryan M et al (2016c) ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation. Nat Commun 7:11600
35. Janssen MCH, de Kleine RH, van den Berg AP et al (2014) Successful liver transplantation and long-term follow-up in a patient with MPI-CDG. Pediatrics 134:e279–e283
36. Kelly DF, Boneh A, Pitsch S et al (2001) Carbohydrate-deficient glycoprotein syndrome 1b: a new answer to an old diagnostic dilemma. J Paediatr Child Health 37:510–512
37. Kjaergaard S, Schwartz M, Skovby F (2001) Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype. Arch Dis Child 85:236–239
38. Kodera H, Ando N, Yuasa I et al (2015) Mutations in COG2 encoding a subunit of the conserved oligomeric golgi complex cause a congenital disorder of glycosylation. Clin Genet 87:455–460
39. Kornak U, Reynders E, Dimopoulou A et al (2008) Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2. Nat Genet 40:32–34
40. Lepais L, Cheillan D, Frachon SC et al (2015) ALG3-CDG: report of two siblings with antenatal features carrying homozygous p.Gly96Arg Mutation. Am J Med Genet 167A:2748–2754
41. Liem YS, Bode L, Freeze HH, Leebeek FWG, Zandbergen AAM, Wilson JHP (2008) Using heparin therapy to reverse protein-losing enteropathy in a patient with CDG-Ib. Nat Clin Pract Gastroenterol Hepatol 5:220–224
42. Mention K, Lacaille F, Valayannopoulos V et al (2008) Development of liver disease despite mannose treatment in two patients with CDG-Ib. Mol Genet Metabol 93:40–43
43. Miura Y, Tay SKH, Aw MM, Eklund E, Freeze HH (2005) Clinical and biochemical characterization of a patient with congenital disorder of glycosylation (CDG) IIX. J Pediatr 147:851–853
44. Monin ML, Mignot C, De Lonlay P et al (2014) 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype. Orphanet J Rare Dis 9:207
45. Monticelli M, Ferro T, Jaeken J, Dos Reis Ferreira V, Videira PA (2016) Immunological aspects of congenital disorders of glycosylation (CDG): a review. J Inherit Metab Dis 39:765–780
46. Morava E (2014) Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG. Mol Genet Metab 112:275–279
47. Morava E, Zeevaert R, Korsch E et al (2007) A common mutation in the COG7 gene with a consistent phenotype including microcephaly, adducted thumbs, growth retardation, VSD and episodes of hyperthermia. Eur J Hum Genet 15:638–665
48. Morava E, Vodopiutz J, Lefeber DJ et al (2012) Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations. Pediatrics 130:e1034–e1039
49. Morava E, Tiemes V, Thiel C et al (2016) ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavior and limb anomalies. J Inherit Metab Dis 39:713–723
50. Ng BG, Kranz C, Hagebeuk EEO et al (2007) Molecular and clinical characterization of a Moroccan Cog7 deficient patient. Mol Genet Metab 91:201–204
51. Ng BG, Sharma V, Sun L et al (2011) Identification of the first COG-CDG patient of Indian origin. Mol Genet Metab 102:364–367
52. Ng BG, Shiryaev SA, Rymen D et al (2016) ALG1-CDG: clinical and molecular characterization of 39 unreported patients. Hum Mutat 37:653–660
53. Niehues R, Hasilik M, Alton G et al (1998) Carbohydrate-deficient glycoprotein syndrome type Ib. phosphomannose isomerase deficiency and mannose therapy. J Clin Invest 101:1414–1420
54. Ono H, Sakura N, Yamashita K, Yuasa I, Ohno K (2003) Novel nonsense mutation (R194X) in the PMM2 gene in a Japanese patient with congenital disorder of glycosylation type Ia. Brain Dev 27:525–528
55. Panneerselvam K, Freeze HH (1996) Mannose enters mammalian cells using a specific transporter that is insensitive to glucose. J Biol Chem 271:9417–9421
56. Reynders E, Foulquier F, Leão Teles E et al (2009) Golgi function and dysfunction in the first COG4-deficient CDG type II patient. Hum Mol Genet 18:3244–3256
57. Rohlfing A-K, Rust S, Reunert J et al (2014) ALG1-CDG: a new case with early fatal outcome. Gene 534:345–351
58. Rymen D, Winter J, Van Hasselt PM et al (2015) Key features and clinical variability of COG6-CDG. Mol Genet Metabol 116:163–170
59. Schollen E, Frank CG, Keldermans L et al (2004) Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency). J Med Genet 41:550–556
60. Serrano M, de Diego V, Muchart J et al (2015) Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment. Orphanet J Rare Dis 10:138
61. Shanti B, Silink M, Bhattacharya K et al (2009) Congenital disorder of glycosylation type Ia: heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency. J Inherit Metab Dis 32:S241–S251
62. Sorte H, Mørkrid L, Rødningen O et al (2012) Severe ALG8-CDG (CDG-Ih) associated with homozygosity for two novel missense mutations detected by exome sequencing of candidate genes. Eur J Med Genet 55:196–202
63. Spaapen LJM, Bakker JA, Van Der Meer SB et al (2005) Clinical and biochemical presentation of siblings with COG-7 deficiency, a lethal multiple O- and N-glycosylation disorder. J Inherit Metab Dis 28:707–714
64. Sparks SE, Krasnewich DM (2014) Congenital disorders of N-linked glycosylation. pathway overview. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K (eds) eneReviews®. University of Washington, Seattle, pp 1993–2016
65. Sun L, Eklund EA, Chung WK, Wang C, Cohen J, Freeze HH (2005) Congenital disorder of glycosylation Id presenting with hyperinsulinemic hypoglycemia and islet cell hyperplasia. J Clin Endocrinol Metab 90:4371–4375
66. Tegtmeyer LC, Rust S, van Scherpenzeel M et al (2014) Multiple phenotypes in phosphoglucomutase 1 deficiency. N Eng J Med 370:533–542
67. Vesela K, Honzik T, Hansikova H et al (2009) A new case of ALG8 deficiency (CDG Ih). J Inherit Metab Dis 32:259–264
68. Vleugels W, Keldermans L, Jaeken J et al (2009) Quality control of glycoproteins bearing truncated glycans in an ALG9-defective (CDG-IL) patient. Glycobiology 19:910–917
69. Weinstein M, Schollen, Matthijs G et al (2005) CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features. Am J Med Genet 136A:194–197
70. Westphal V, Kjaergaard S, Davis JÁ, Peterson SM, Skovby F, Freeze HH (2001) Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation. Mol Genet Metabol 73:77–85
71. Wong SY, Beamer LJ, Gadomski T et al (2016) Defining the phenotype and assessing severity in phosphoglucomutase-1 deficiency. J Pediatr 175:130–136
72. Wu X, Steet RA, Bohorov O et al (2004) Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat Med 10:518–523
73. Zeevaert R, Foulquier F, Cheillan D et al (2009) A new mutation in COG7 extends the spectrum of COG subunit deficiencies. Eur J Med Genet 52:303–305